Immune signalling in neural development, synaptic plasticity and disease

Nature Reviews Neuroscience

Volumn 5, Issue 7, 2004, Pages 521-531

  Boulanger, Lisa M ^a   Shatz, Carla J ^b  

^a NEUROBIOLOGY SECTION   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AUTISM; BEHAVIOR; BRAIN DEVELOPMENT; DYSLEXIA; GENETIC LINKAGE; GENETIC RISK; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; RIBONUCLEASE PROTECTION ASSAY; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 3042841709     PISSN: 1471003X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrn1428     Document Type: Review

References (124)

1. Rall, G. F., Mucke, L. & Oldstone, M. B. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo. J. Exp. Med. 182, 1201-1212 (1995).
2. Joly, E., Mucke, L. & Oldstone, M. B. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253, 1283-1285 (1991).
3. Lampson, L. A., Whelan, J. P. & Siegel, G. Functional implications of class I MHC modulation in neural tissue. Ann. NY Acad. Sci. 540, 479-482 (1988).
4. Fujimaki, H., Hikawa, N., Nagoya, M., Nagata, T. & Minami, M. IFN-γ-induces expression of MHC class I molecules in adult mouse dorsal root ganglion neurones. Neuroreport 7, 2951-2955 (1996).
5. Joly, E. & Oldstone, M. B. Neuronal cells are deficient in loading peptides onto MHC class I molecules. Neuron 8, 1185-1190 (1992).
6. Drew, P. D. et al. Regulation of MHC class I and β2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes. J. Immunol. 150, 3300-3310 (1993).
7. White, L. A., Keane, R. W. & Whittemore, S. R. Differentiation of an immortalized CNS neuronal cell line decreases their susceptibility to cytotoxic T cell lysis in vitro. J. Neuroimmunol. 49, 135-143 (1994).
8. Lampson, L. A. & Fisher, C. A. Weak HLA and β2-microglobulin expression of neuronal cell lines can be modulated by interferon. Proc. Natl Acad. Sci. USA 81, 6476-6480 (1984).
9. Lampson, L. A. Interpreting MHC class I expression and class I/class II reciprocity in the CNS: reconciling divergent findings. Microsc. Res. Tech. 32, 267-285 (1995).
10. Olsson, T et al. γ-Interferon-like immunoreactivity in axotomized rat motor neurons. J. Neurosci. 9, 3870-3875 (1989).
11. Maehlen, J., Schroder, H. D., Klareskog, L., Olsson, T. & Kristensson, K. Axotomy induces MHC class I antigen expression on rat nerve cells. Neurosci. Lett. 92, 8-13 (1988).
12. Lidman, O., Olsson, T. & Piehl, F. Expression of nonclassical MHC class I (RT1-U) in certain neuronal populations of the central nervous system. Eur. J. Neurosci. 11, 4468-4472 (1999).
13. Redwine, J. M., Buchmeier, M. J. & Evans, C. F. In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection. Am. J. Pathol. 159, 1219-1224 (2001).
14. Pereira, R. A., Tscharke, D. C. & Simmons, A. Upregulation of class I major histocompatibility complex gene expression in primary sensory neurons, satellite cells, and Schwann cells of mice in response to acute but not latent herpes simplex virus infection in vivo. J. Exp. Med. 180, 841-850 (1994).
15. Foster, J. A., Quan, N., Stern, E. L., Kristensson, K. & Herkenham, M. Induced neuronal expression of class I major histocompatibility complex mRNA in acute and chronic inflammation models. J. Neuroimmunol. 131, 83-91 (2002).
16. Wong, G. H., Bartlett, P. F., Clark-Lewis, I., Battye, F. & Schrader, J. W. Inducible expression of H-2 and Ia antigens on brain cells. Nature 310, 688-691 (1984).
17. Neumann, H., Cavalie, A., Jenne, D. E. & Wekerle, H. Induction of MHC class I genes in neurons. Science 269, 549-552 (1995).
18. Neumann, H., Schmidt, H., Cavalie, A., Jenne, D. & Wekerle, H. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-γ and tumor necrosis factor (TNF)-α. J. Exp. Med. 185, 305-316 (1997).
19. Linda, H. et al. Expression of MHC class I and β2-microglobulin in rat spinal motoneurons: regulatory influences by IFN-γ and axotomy. Exp. Neurol. 150, 282-295 (1998).
20. Corriveau, R. A., Huh, G. S. & Shatz, C. J. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 21, 505-520 (1998). This study first identified MHC class I in an unbiased screen for genes involved in activity-dependent plasticity. MHC was found to be expressed by neurons and regulated by activity in the adult and developing mammalian brain.
21. Huh, G. S. et al. Functional requirement for class I MHC in CNS development and plasticity. Science 290, 2155-2159 (2000). Using mice deficient for most MHC class I genes, this study determined that MHC class I is required for normal activity-dependent refinement of developing visual projections as well as normal long-term potentiation and long-term depression in the adult hippocampus.
22. Neumann, H., Schmidt, H., Wilharm, E., Behrens, L. & Wekerle, H. Interferon-γ gene expression in sensory neurons: Evidence for autocrine gene regulation. J. Exp. Med. 186, 2023-2031 (1997).
23. Linda, H., Hammarberg, H., Piehl, F., Khademi, M. & Olsson, T. Expression of MHC class I heavy chain and β2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons. J. Neuroimmunol. 101, 76-86 (1999).
24. Loconto, J. et al. Functional expression of murine V2R pheromone receptors involves selective association with the M10 and M1 families of MHC class Ib molecules. Cell 112, 607-618 (2003). MHC class Ib (non-classical) genes were identified in an unbiased screen for genes that were coexpressed with a subset of pheromone receptors in the VNO, where they might be involved in pheromone receptor delivery to the cell surface, as well as gender identification behaviours.
25. Ishii, T., Hirota, J. & Mombaerts, P. Combinatorial coexpression of neural and immune multigene families in mouse vomeronasal sensory neurons. Curr. Biol. 13, 394-400 (2003). In parallel with the above study, members of the H2-M non-classical MHC class I family were identified in vomeronasal sensory neurons and were found to be expressed in complex and nonrandom cellular association with specific pheromone receptors.
26. Binder, G. K. & Griffin, D. E. Interferon-γ-mediated site-specific clearance of alphavirus from CNS neurons. Science 293, 303-306 (2001).
27. Dalziel, R. G., Lampert, P. W., Talbot, P. J. & Buchmeier, M. J. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 59, 463-471 (1986).
28. Fazakerley, J. K., Parker, S. E., Bloom, F. & Buchmeier, M. J. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology 187, 178-188 (1992).
29. Duan, W. M., Westerman, M., Flores, T. & Low, W. C. Survival of intrastriatal xenografts of ventral mesencephalic dopamine neurons from MHC-deficient mice to adult rats. Exp. Neurol. 167, 108-117 (2001).
30. Veng, L. M. et al. Xenografts of MHC-deficient mouse embryonic mesencephalon improve behavioral recovery in hemiparkinsonian rats. Cell Transplant. 11, 5-16 (2002).
31. Pakzaban, P., Deacon, T. W., Burns, L. H., Dinsmore, J. & Isacson, O. A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 65, 983-996 (1995).
32. Ransohoff, R. M., Kivisakk, P. & Kidd, G. Three or more routes for leukocyte migration into the central nervous system. Nature Rev. Immunol. 3, 569-581 (2003).
33. Catipovic, B. et al. Analysis of the structure of empty and peptide-loaded major histocompatibility complex molecules at the cell surface. J. Exp. Med. 180, 1753-1761 (1994).
34. Pereira, R. A. & Simmons, A. Cell surface expression of H2 antigens on primary sensory neurons in response to acute but not latent herpes simplex virus infection in vivo. J. Virol. 73, 6484-6489 (1999).
35. Tumley, A. M., Starr, R. & Bartlett, P. F. Failure of sensory neurons to express class I MHC is due to differential SOCS1 expression. J. Neuroimmunol. 123, 35-40 (2002).
36. Boulanger, L. M., Huh, G. S. & Shatz, C. J. Neuronal plasticity and cellular immunity: shared molecular mechanisms. Curr. Opin. Neurobiol. 11, 568-578 (2001).
37. + cytolytic T cells. Nature 344, 742-746 (1990).
38. + T cells. Cell 71, 1205-1214 (1992). References 37 and 38 detail development and characterization of two lines of mutant mice deficient in MHC class I cell surface expression - valuable tools for studying MHC class I functions in the immune system and beyond.
39. deSousa, M. et al. Iron overload in β2-microglobulin-deficient mice. Immunol. Lett. 39, 105-111 (1994).
40. Moos, T., Tinder, D. & Morgan, E. H. Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and β2-microglobulin deficient mouse brain. Cell Mol. Biol. (Noisy-le-grand) 46, 549-561 (2000).
41. Rothenberg, B. E. & Voland, J. R. β2-knockout mice develop parenchymal iron overload: a putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc. Natl Acad. Sci. USA 93, 1529-1534 (1996).
42. Dulac, C. & Torello, A. T. Molecular detection of pheromone signals in mammals: from genes to behaviour. Nature Rev. Neurosci. 4, 551-562 (2003).
43. Moretta, A. et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155, 105-117 (1997).
44. Ugolini, S. & Vivier, E. Regulation of T cell function by NK cell receptors for classical MHC class I molecules. Curr. Opin. Immunol. 12, 295-300 (2000).
45. Trowsdale, J. et al. The genomic context of natural killer receptor extended gene families. Immunol. Rev. 181, 20-38 (2001).
46. Bakker, A. B., Wu, J., Phillips, J. H. & Lanier, L. L. NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals. Hum. Immunol. 61, 18-27 (2000).
47. Kane, K. P., Silver, E. T. & Hazes, B. Specificity and function of activating Ly-49 receptors. Immunol. Rev. 181, 104-114 (2001).
48. Klausner, R. D., Weissman, A. M., Baniyash, M., Bonifacino, J. S. & Samelson, L. E. The role of the ζ-chain in the expression, structure and function of the T cell receptor. Adv. Exp. Med. Biol. 254, 21-24 (1989).
49. Syken, J. & Shatz, C. J. Expression of T cell receptor β-locus in central nervous system neurons. Proc. Natl Acad. Sci. USA 100, 13048-13053 (2003). This study found striking and dynamic expression of mRNA encoding an unrecombined β-subunit of the TCR in the developing and adult mouse CNS, including in the thalamic nuclei and deep layers of cortex.
50. Nishiyori, A., Hanno, Y., Saito, M. & Yoshihara, Y. Aberrant transcription of unrearranged T-cell receptor β-gene in mouse brain. J. Comp. Neurol. 469, 214-226 (2004).
51. Wilson, I. A. & Bjorkman, P. J. Unusual MHC-like molecules: CD1, Fc receptor, the hemochromatosis gene product, and viral homologs. Curr. Opin. Immunol. 10, 67-73 (1998).
52. Feder, J. N. et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet. 13, 399-408 (1996).
53. Parkkila, S. et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc. Natl Acad. Sci. USA 94, 13198-13202 (1997).
54. Feder, J. N. et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl Acad. Sci. USA 95, 1472-1477 (1998).
55. Feder, J. N. et al. The hemochromatosis founder mutation in HLA-H disrupts β2-microglobulin interaction and cell surface expression. J. Biol. Chem. 272, 14025-14028 (1997).
56. Burmeister, W. P., Gastinel, L. N., Simister, N. E., Blum, M. L. & Bjorkman, P. J. Crystal structure at 2.2 Å resolution of the MHC-related neonatal Fc receptor. Nature 372, 336-343 (1994).
57. Burmeister, W. P., Huber, A. H. & Bjorkman, P. J. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 372, 379-383 (1994).
58. Ojcius, D. M., Delarbre, C., Kourilsky, P. & Gachelin, G. MHC and MHC-related proteins as pleiotropic signal molecules. FASEB J. 16, 202-206 (2002).
59. Stein, J. The magnocellular theory of developmental dyslexia. Dyslexia 7, 12-36 (2001).
60. Rubinstein, G. Schizophrenia, rheumatoid arthritis and natural resistance genes. Schizophr. Res. 25, 177-181 (1997).
61. Torres, A. R., Maciulis, A. & Odell, D. The association of MHC genes with autism. Front. Biosci. 6, D936-943 (2001).
62. Tiwari, J. L. & Terasaki, P. I. HLA and Disease Associations (Springer-Verlag, New York, 1985).
63. Howard, J. & Thompson, I. First class way to develop a brain. Nature 396, 219-221 (1998).
64. Darnell, R. B. Immunologic complexity in neurons. Neuron 21, 947-950 (1998).
65. Rivera-Quinones, C. et al. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nature Med. 4, 187-193 (1998).
66. Neumann, H., Medana, I. M., Bauer, J. & Lassmann, H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25, 313-319 (2002).
67. Damell, R. B. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc. Natl Acad. Sci. USA 93, 4529-4536 (1996).
68. Albert, M. L. & Damell, R. B. Paraneoplastic neurological degenerations: keys to tumour immunity. Nature Rev. Cancer 4, 36-44 (2004).
69. Schwartz, M., Moalem, G., Leibowitz-Amit, R. & Cohen, I. R. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 22, 295-299 (1999).
70. Yoles, E. et al. Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21, 3740-3748 (2001).
71. Rothermundt, M., Arolt, V. & Bayer, T. A. Review of immunological and immunopathological findings in schizophrenia. Brain Behav. Immun. 15, 319-339 (2001).
72. Karayiorgcu, M. & Gogos, J. A. A turning point in schizophrenia genetics. Neuron 19, 967-979 (1997).
73. Schwab, S. G. et al. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol. Psychiatry 5, 638-649 (2000).
74. Smeraldi, E., Bellodi, L. & Cazzullo, C. L. Further studies on the major histocompatibility complex as a genetic marker for schizophrenia. Biol. Psychiatry 11, 655-661 (1976).
75. Wright, P., Nimgaonkar, V. L., Donaldson, P. T. & Murray, R. M. Schizophrenia and HLA: a review. Schizophr. Res. 47, 1-12 (2001).
76. Cardno, A. G. et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch. Gen. Psychiatry 56, 162-168 (1999).
77. Torrey, E. F. Are we overestimating the genetic contribution to schizophrenia? Schizophr. Bull. 18, 159-170 (1992).
78. Brown, A. S. et al. Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: A prospective birth cohort study. Schizophr. Bull. 26, 287-295 (2000).
79. Fatemi, S. H. et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell. Mol. Neurobiol. 22, 25-33 (2002). This and several other elegant studies have shown that prenatal viral infection is a significant risk factor for neurodevelopmental abnormalities, perhaps through changes in cytokine expression in the fetal CNS.
80. Shima, S., Yano, K., Sugiura, M. & Tokunaga, Y. Anticerebral antibodies in functional psychoses. Biol. Psychiatry 29, 322-328 (1991).
81. Woitanowska, M. & Rybakowski, J. Changes of humoral and cellular immunity in schizophrenia. Psychiatr. Pol. 30, 783-799 (1996).
82. Aroit, V., Rothermundt, M., Wandinger, K. P. & Kirchner, H. Decreased in vitro production of interferon-γ and interleukin-2 in whole blood of patients with schizophrenia during treatment. Mol. Psychiatry 5, 150-158 (2000).
83. Nawa, H., Takahashi, M. & Patterson, P. H. Cytokine and growth factor involvement in schizophrenia - support for the developmental model. Mol. Psychiatry 5, 594-603 (2000).
84. Ganguli, R. et al. Autoimmunity in schizophrenia: a review of recent findings. Ann. Med. 25, 489-496 (1993).
85. Wright, P. et al. Autoimmune diseases in the pedigrees of schizophrenic and control subjects. Schizophr. Res. 20, 261-267 (1996).
86. Finney, G. O. Juvenile onset diabetes and schizophrenia? Lancet 2, 1214-1215 (1989).
87. Eaton, W. W., Hayward, C. & Ram, R. Schizophrenia and rheumatoid arthritis: a review. Schizoph. Res. 6, 181-192 (1992).
88. McAllister, C. G. et al. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am. J. Psychiatry 152, 1291-1297 (1995).
89. Degreef, G. et al. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch. Gen. Psychiatry 49, 531-537 (1992).
90. Keshavan, M. S., Anderson, S. & Pettegrew, J. W. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J. Psychiatr. Res. 28, 239-265 (1994).
91. Warren, R. P. et al. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics 36, 203-207 (1992).
92. Daniels, W. W. et al. Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Neuropsychobiology 32, 120-123 (1995).
93. Warren, R. P. et al. Strong association of the third hypervariable region of HLA-DR β1 with autism. J. Neuroimmunol. 67, 97-102 (1996).
94. Yonan, A. L. et al. A genomewide screen of 345 families for autism-susceptibility loci. Am. J. Hum. Genet. 73, 886-897 (2003).
95. Torres, A. R., Maciulis, A., Stubbs, E. G., Cutler, A. & Odell, D. The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum. Immunol. 63, 311-316 (2002).
96. Lauritsen, M. & Ewald, H. The genetics of autism. Acta Psychiatr. Scand. 103, 411-427 (2001).
97. Chess, S. Follow-up report on autism in congenital rubella. J. Autism Child. Schizophr. 7, 69-81 (1977).
98. Desmond, M. M. et al. Congenital rubella encephalitis. Course and early sequelae. J. Pediatr. 71, 311-331 (1967).
99. Stubbs, E. G., Ash, E. & Williams, C. P. Autism and congenital cytomegalovirus. J. Autism Dev. Disord. 14, 183-189 (1984).
100. Stubbs, E. G. & Crawford, M. L. Depressed lymphocyte responsiveness in autistic children. J. Autism Child. Schizophr. 7, 49-55 (1977).
101. +) T cells in autism. Immunol. Invest. 19, 245-251 (1990).
102. Denney, D. R., Frei, B. W. & Gaffney, G. R. Lymphocyte subsets and interleukin-2 receptors in autiStic children. J. Autism Dev. Disord. 26, 87-97 (1996).
103. Warren, R. P., Foster, A. & Margaretten, N. C. Reduced natural killer cell activity in autism. J. Am. Acad. Child Adolesc. Psychiatry 26, 333-335 (1987).
104. Warren, R. P., Burger, R. A., Odell, D., Torres, A. R. & Warren, W. L. Decreased plasma concentrations of the C4B complement protein in autism. Arch. Pediatr. Adolesc. Med. 146, 180-183 (1994).
105. Dalton, P. et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann. Neurol. 53, 533-537 (2003).
106. Warren, R. P. et al. Increased frequency of the null allele at the complement C4b locus in autism. Clin. Exp. Immunol. 83, 438-440 (1991).
107. Warren, R. P. et al. Detection of maternal antibodies in infantile autism. J. Am. Acad. Child Adolesc. Psychiatry 29, 873-877 (1990).
108. Singh, V. K., Warren, R., Averett, R. & Ghaziuddin, M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 17, 88-90 (1997).
109. Connolly, A. M. et al. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J. Pediatr. 134, 607-613 (1999).
110. Krause, I., He, X. S., Gershwin, M. E. & Shoenfeld, Y. Brief report: immune factors in autism: a critical review. J. Autism Dev. Disord. 32, 337-345 (2002).
111. Courchesne, E., Carper, R. & Akshoomoff, N. Evidence of brain overgrowth in the first year of life in autism. JAMA 290, 337-344 (2003).
112. Fisher, S. E. & DeFries, J. C. Developmental dyslexia: genetic dissection of a complex cognitive trait. Nature Rev. Neurosci. 3, 767-780 (2002).
113. Cardon, L. R. et al. Quantitative trait locus for reading disability on chromosome 6. Science 266, 276-279 (1994). This study was the first to show a strong genetic link between the MHC class I region and developmental dyslexia.
114. Pennington, B. F., Smith, S. D., Kimberling, W. J., Green, P. A. & Haith, M. M. Left-handedness and immune disorders in familial dyslexics. Arch. Neurol. 44, 634-639 (1987).
115. Hugdahl, K., Synnevag, B. & Satz, P. Immune and autoimmune diseases in dyslexic children. Neuropsychologia 28, 673-679 (1990).
116. Behan, W. M., Behan, P. O. & Geschwind, N. Anti-Ro antibody in mothers of dyslexic children. Dev. Med. Child Neurol. 27, 538-540 (1985).
117. Vincent, A. et al. Maternal antibody-mediated dyslexia? Evidence for a pathogenic serum factor in a mother of two dyslexic children shown by transfer to mice using behavioural studies and magnetic resonance spectroscopy. J. Neuroimmunol. 130, 243-247 (2002).
118. Witton, C. et al. Sensitivity to dynamic auditory and visual stimuli predicts nonword reading ability in both dyslexic and normal readers. Curr. Biol. 8, 791-797 (1998).
119. Stein, J. The neurobiology of reading difficulties. Prostaglandins Leukot. Essent. Fatty Acids 63, 109-116 (2000).
120. Kulski, J. K., Shiina, T., Anzai, T., Kohara, S. & Inoko, H. Comparative genomic analysis of the MHC: the evolution of class I duplication blocks, diversity and complexity from shark to man. Immunol Rev 190, 95-122 (2002).
121. Gunther, E. & Walter, L. Comparative genomic aspects of rat, mouse and human MHC class I gene regions. Cytogenet. Cell Genet. 91, 107-112 (2000).
122. Heinrichs, H. & Orr, H. T. HLA non-A,B,C class I genes: their structure and expression. Immunol. Res. 9, 265-274 (1990).
123. Hedrick, S. M. Dawn of the hunt for nonclassical MHC function. Cell 70, 177-180 (1992).
124. Mignot, E. Genetic and familial aspects of narcolepsy. Neurology 50, S16-22 (1998).